mk2 Biotechnologies

📍 Planegg, Germany🗓 Founded 2020👥 19 employees💰 Last funded Jun 2023
Biotechnology Research🌐 mk2.bio
Website LinkedIn
mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications.
7
Total investors
4
Early stage
3
Mid stage
0
Late stage
2020
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
Austria
3
Germany
2
Saudi Arabia
1
Switzerland
1
Investor activity2021–2023 · investors recorded per year
2021420233
Recent (last 2y)Earlier
Frequently asked questions
Who invested in mk2 Biotechnologies?
mk2 Biotechnologies has 7 investors on record on gritt.io, including 4 early-stage backers, 3 mid-stage.
When did mk2 Biotechnologies last raise funding?
The most recent investment in mk2 Biotechnologies recorded on gritt.io was in June 2023.
When was mk2 Biotechnologies founded?
mk2 Biotechnologies was founded in 2020.
What industry is mk2 Biotechnologies in?
mk2 Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is mk2 Biotechnologies based?
mk2 Biotechnologies is headquartered in Planegg, Germany.